Anjana Narain

Anjana Narain currently serves as the Head of Takeda Vaccines, a position held since July 2023. Previously, Anjana was the Managing Director and Founder of Mobisevak Solutions LLP, focusing on bridging the digital divide in underserved communities in India. Anjana has extensive experience as an advisor for IIVPM.com and Private Equity Pro Partners, and as the Founder and Managing Partner of Twenty Four By Seven Strategies LLP, which aims to promote health equity. Anjana's prior roles include EVP and General Manager at Seqirus, where oversight of a $1 billion vaccines P&L and leadership of a global organization were pivotal, as well as a range of positions at GSK and Merck, contributing to successful product launches and strategic growth initiatives. Anjana holds an MBA from the University of New Haven, a degree in Advertising & PR from the Indian Institute of Mass Communication, and participated in the General Management Program at Harvard Business School.